Key facts
- MedicQuant’s last known valuation is $4.6M (Mar 2023).
- It has raised $23.8M; the latest was Seed Round ($22.0M) in Mar 2026.
- Notable investors include InnoFounder, Denmark's Export and Investment Fund, Nordic Mentor Network For Entrepreneurship, BioInnovation Institute, Aarhus University — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for MedicQuant
- ·The full record, as it builds
Funding rounds
No funding rounds for MedicQuant are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MedicQuant
Developer of a rapid testing instrument designed to detect Direct Oral Anticoagulants (DOACs) at the point-of-care. The company offers a chip that can detect blood levels of the anticoagulants directly from blood samples, enabling hospitals to provide an available test to use in individual departments to benefit patients.
- Sector
- Healthcare
- HQ
- Aarhus, Denmark
- Founded
- 2019
- Employees
- 9
- Website
- medicquant.com/
- Ownership
- Privately Held (backing)
MedicQuant doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedicQuant shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedicQuant in its N-PORT filings yet. We sweep new filings monthly.